Mr. Bixby has been advancing biotechnology to benefit the public health across applications spanning environment, food tech, diagnostics, therapeutics, biodefense, bioremediation, and invasive species control interventions, globally for over 20 years.
His experience as a life sciences, biotechnology and public health professional has focused on development of advanced technologies with applications applicable to human and animal health, food, and environmental interventions, as well as, national security, conservation, sustainable agriculture, waste-to-value, alternative fuels, and consumer products.
He has cross-functional experience developing, deploying and evaluating technologies for clinical, public health, environmental health, and biodefense programs including biological threat detection systems and various therapeutic and vaccine medical countermeasures. He also has advanced several regulated first-in-class genetic engineering technologies, as well as gene-edited and genetically engineered organisms reviewed by FDA, EPA, USDA, USFWS and CDC. Additionally, his technical and commercial experience with international launching of advanced technologies has been informed by having helped develop multiple infectious disease diagnostics including molecular tests for the safety of the U.S. blood supply and other nations, which also greatly enhanced later efforts to evaluate and deploy critical diagnostic interventions in low resource settings across developing countries in Sub-Saharan Africa.
His world view has been further formed through graduate research in epidemiology with strong focus in governmental and regulatory policies affecting environmental and public health, biotechnology, synthetic biology and genetic engineering. Mr. Bixby has multi-disciplinary expertise in new product development, technology analysis, M&A diligence, basic and applied research, project management, marketing, business development, strategic alliances, and leading teams.
Mr. Bixby is also a great proponent of interventions aimed at Public Health, One Health and Planetary Health.